Drug-like property-driven optimization of 4-substituted 1,5-diarylanilines as potent HIV-1 non-nucleoside reverse transcriptase inhibitors against rilpivirine-resistant mutant virus
Keywords: OGVXBOUFKSTFLN-ONEGZZNKSA-N; MFHNFITUWQJMEV-UHFFFAOYSA-N; ATLXYJKTXBKHNW-UHFFFAOYSA-N; ABCRBEXBTOTNJG-UHFFFAOYSA-N; XHRNTQCVULTCLC-SNAWJCMRSA-N; CUGXLXTYORXILY-HWKANZROSA-N; NXWFUKNVRMQPGM-ONEGZZNKSA-N; ZUHDQBIGOBSRMK-HWKANZROSA-N; CPYABBSGVVVLAO-ONEGZZNK